Background: Plasma natriuretic peptide levels may be useful in the diagnosis of heart
failure. The available natriuretic peptide assays differ markedly in their performance …

There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides)
plasma concentration may be elevated in many clinical conditions besides cardiovascular …

Tremendous advances have been made in understanding the pathophysiology and
treatment of congestive heart failure (CHF). However, diagnosis still remains difficult, even …

Background Cardiac natriuretic peptides are activated in heart failure. However, their
diagnostic and prognostic values have not been compared under the routine conditions of …

Natriuretic peptides (NPs) were first described as cardiac biomarkers more than two
decades ago. Since that time, numerous studies have confirmed NPs' diagnostic and …

The natriuretic peptides are a family of related hormones that play a crucial role in
cardiovascular homeostasis. They have recently emerged as potentially important clinical …

Background: Natriuretic peptides are currently used in the diagnosis and follow‐up of
patients with Chronic Heart Failure (CHF). However, it is unknown whether there are …

The long-predicted endocrine function of the heart has been proven by the discovery of atrial
natriuretic peptide (atrial natriuretic factor, A-type natriuretic peptide; ANP) 20 years ago …

Assays for natriuretic peptides have received considerable attention as potential screening
tests for congestive heart failure and left ventricular dysfunction. However, information …

The discovery of cardiac natriuretic peptides two decades ago has lead to considerable
research to investigate their biochemical and physiological properties. Clearly the heart is …